To elucidate the mechanism by which IGF2BP3 deficiency mitigates liver fibrosis and suppresses HSC activation, m6A RIP‐seq was conducted on isolated primary HSCs (Figure 6A). Here, IGF2BP3 is linked to Hepatic fibrosis.